Description BPC-157 BPC-157 (Body Protection Compound 157) is a synthetic pentadecapeptide studied in preclinical models for its roles in tissue repair signaling, angiogenesis, nitric oxide modulation, and gastrointestinal mucosal research
Dosing Protocols for Injury Recovery There is no FDA-approved dosing for BPC 157 and TB 500, but anecdotal use often follows patterns like: BPC 157: 200500 mcg daily, sometimes injected near the injury
Heating can degrade peptides, so working at room temperature is advisable
AOD 9604 long-term outlook The long-term safety data for AOD 9604 is limited because the clinical development program was terminated
Change either number and your final concentration changes proportionally
For musculoskeletal or systemic targets, injections are the better-supported route based on existing animal data